Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links
Cat.#: ACPP-1204
| Despition | P2Y1 Blocking Peptide for Immunodepletion, Immunocompetition |
| SIZE | 250 µg |
| Applications | Immunodepletion & Immunocompetition assay |
| Storage | Store at -20⁰C for long term |
| Shipping | Shipped at 4°C |
| Cat.# | Name | Size | Price |
|---|---|---|---|
| ACPP-1774 | Human CRKL Protein (AC1774) | 5 µg | inquiry |
| ACPP-1636 | Vasopressin (AC1636) | 5 mg | inquiry |
| ACPP-1074 | Myocilin Blocking Peptide (AC1074) | 250 µg | inquiry |
| ACPP-1112 | Recombinant Human Eph Receptor A2 Protein (6×His Tag) (AC1112) | 50 µg | inquiry |
| ACPP-1392 | Human Dopa Decarboxylase Protein (AC1392) | 5 µg | inquiry |
| ACPP-1029 | Recombinant Human beta Nerve Growth Factor Protein (AC1029) | 50 µg | inquiry |
| ACPP-1393 | Human ALDH3A1 Protein (AC1393) | 2 µg | inquiry |
| ACPP-1258 | Pannexin 1 Blocking Peptide (AC1258) | 250 µg | inquiry |
| ACPP-1558 | Human ALK/P80 Protein (AC1558) | 2 µg | inquiry |
| ACPP-1245 | CRMP2 Blocking Peptide (AC1245) | 250 µg | inquiry |
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.